Origin Therapeutics Holdings (XCNQ:ORIG) Market Cap : C$1.41 Mil (As of Jun. 10, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Origin Therapeutics Holdings's share price for the quarter that ended in Jun. 2023 was C$0.025. Origin Therapeutics Holdings's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 56.56 Mil. Therefore, Origin Therapeutics Holdings's market cap for the quarter that ended in Jun. 2023 was C$1.41 Mil.

Origin Therapeutics Holdings's quarterly market cap increased from Dec. 2022 (C$1.13 Mil) to Mar. 2023 (C$1.41 Mil) but then stayed the same from Mar. 2023 (C$1.41 Mil) to Jun. 2023 (C$1.41 Mil).

Origin Therapeutics Holdings's annual market cap stayed the same from . 20 (C$0.00 Mil) to Sep. 2021 (C$0.00 Mil) but then increased from Sep. 2021 (C$0.00 Mil) to Sep. 2022 (C$2.55 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Origin Therapeutics Holdings's Enterprise Value for Today is C$-3.65 Mil.

Origin Therapeutics Holdings Market Cap Historical Data

The historical data trend for Origin Therapeutics Holdings's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Market Cap Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Market Cap

2.55

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Market Cap	Get a 7-Day Free Trial				4.24	2.55	1.13	1.41	1.41

Competitive Comparison of Origin Therapeutics Holdings's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Market Cap distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Market Cap falls into.

Origin Therapeutics Holdings Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Origin Therapeutics Holdings's Market Cap for the fiscal year that ended in Sep. 2022 is calculated as

Market Cap (A: Sep. 2022 )	=	Share Price (A: Sep. 2022 )	*	Shares Outstanding (EOP) (A: Sep. 2022 )
	=	C$0.045	*	56.563
	=	C$2.55

Origin Therapeutics Holdings's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	C$0.025	*	56.563
	=	C$1.41

Origin Therapeutics Holdings (XCNQ:ORIG) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Origin Therapeutics Holdings Market Cap Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.